AKT1 and breast carcinoma: To sum up, our results show that TRPV3 up-regulated in breast cancer, and inhibiting TRPV3 significantly promotes MCF-7 cell apoptosis, inhibits cell migration and proliferation through targeting EGFR/AKT pathway.